Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop
Mattia Arrigo(University Hospital of Zurich), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), David A. Baran(Cleveland Clinic), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Yves Rosenberg(National Institutes of Health), Martine Gilard(Hôpital Maison Blanche), Bruno Lévy(Centre Hospitalier Régional et Universitaire de Nancy), Hölger Thiele(Leipzig Heart Institute), Laurent Bonello(Assistance Publique Hôpitaux de Marseille), Pascal Leprince(Sorbonne Université), Janine Pöss(Leipzig Heart Institute), Étienne Gayat(Inserm), Maciej Kostrubiec(Medical University of Warsaw), Mahir Karakas(Universität Hamburg), Uwe Zeymer(University of Freiburg), Michael O. Harhay(California University of Pennsylvania), Bruno François(Inserm), Navin K. Kapur(Tufts Medical Center), Nadia Aïssaoui(Assistance Publique – Hôpitaux de Paris), Susanna Price(Royal Brompton Hospital)
Cited by 52
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k